US09075X2071
US09075X2071
Biodesix, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 274.54M EUR | 237.9M EUR | 146.55M EUR | 56.12M EUR |
Enterprise Value | 312.23M EUR | 279.7M EUR | 192.59M EUR | 109.99M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -118.27x | -- | -- | -- |
Price to Sales | 2.67x | 2.31x | 1.53x | 0.8x |
Price to Book | 30.01x | 26.02x | 16.05x | -- |
EV/Revenue | 3.03x | 2.72x | 2x | 1.56x |
EV/EBITDA | -20.81x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -3.97% | -8.58% | -17.23% | -26.61% |